Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Main Authors: | Michal Kýr, Giannoula Lakka Klement, Lenka Zdrazilova-Dubska, Regina Demlova, Dalibor Valik, Ondrej Slaby, Irene Slavc, Jaroslav Sterba |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00377/full |
Similar Items
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
by: Kristyna Polaskova, et al.
Published: (2020-02-01) -
Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Published: (2020) -
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
by: Lenka Fedorova, et al.
Published: (2019-11-01) -
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
by: Johannes Gojo, et al.
Published: (2020-01-01) -
Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
by: Michal Kyr, et al.
Published: (2019-07-01)